varicella zoster virus glycoprotein e antigen (Shingrix) Report issue

Vaccine Approved FDA
AACT

Active Ingredient History

NOW
  • Now
A zoster vaccine is a vaccine that reduces the incidence of herpes zoster (shingles), a disease caused by reactivation of the varicella zoster virus, which is also responsible for chickenpox. Shingles provokes a painful rash with blisters, and can be followed by chronic pain, as well as other complications. Older people are more often affected, as are people with weakened immune systems (immunosuppression). Both shingles and postherpetic neuralgia can be prevented by vaccination.   Wikipedia

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: Missing data
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: Missing data

Alternative names

hz/su vaccine | varicella zoster virus glycoprotein e antigen | vzv vaccine

Organizations (45)

Research & Development (45)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (1)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (47)

Approved Indications (1)


 

Varicella Zoster Virus Infection (approved 2017)

Experimental Indications - Clinical Trial Phases 1-4 (47)


 

Allergy and Immunology (Early Phase 1)

Arthritis, Juvenile (Phase 4)

Arthritis, Rheumatoid (Phase 4)

Axial Spondyloarthritis (Phase 4)

Behcet Syndrome (Phase 4)

Bone Marrow Transplantation (Phase 2)

Chickenpox (Phase 2/Phase 3)

Colitis, Ulcerative (Phase 4)

Coronavirus Infections (Early Phase 1)

Crohn Disease (Phase 4)

Dermatomyositis (Phase 4)

Drug-Related Side Effects and Adverse Reactions (Phase 4)

Esophageal Achalasia (Phase 4)

Healthy Volunteers (Phase 4)

Hematopoietic Stem Cell Transplantation (Phase 2)

Herpesvirus 3, Human (Phase 4)

Herpes Zoster (Phase 4)

Herpes Zoster Vaccine (Phase 4)

HIV Infections (Phase 4)

Humans (Phase 2)

Immunosuppression Therapy (Phase 2/Phase 3)

Inflammatory Bowel Diseases (Phase 4)

Injection Site Reaction (Phase 4)

Kidney Transplantation (Phase 4)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)

Liver Diseases (Phase 2/Phase 3)

Lung Diseases (Phase 2)

Lupus Erythematosus, Systemic (Phase 4)

Lymphoma (Phase 4)

Lymphoma, Primary Cutaneous Anaplastic Large Cell (Phase 2)

Myositis (Phase 4)

Neuroblastoma (Phase 1)

Osteosarcoma (Phase 1)

Pain (Phase 4)

Pharmacological and Toxicological Phenomena (Phase 2)

Quality of Life (Phase 4)

Respiratory Syncytial Viruses (Phase 3)

Respiratory Syncytial Virus Infections (Phase 3)

Scleroderma, Systemic (Phase 4)

Sjogren's Syndrome (Phase 4)

Spondylitis, Ankylosing (Phase 4)

Systemic Vasculitis (Phase 4)

Vaccination (Phase 4)

Vaccine-Preventable Diseases (Phase 1)

Vaccines (Phase 4)

Varicella Zoster Virus Infection (Phase 4)

Waldenstrom Macroglobulinemia (Early Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 44
  • # of Trial Organizations: 45

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue